Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 66
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cureus ; 16(3): e56679, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-38646341

RESUMO

A sarcomatoid variant of urothelial carcinoma (SVUC) is an extremely rare variant, which accounts for only 0.1-0.3% of all urothelial carcinomas of the bladder. SVUC is distinguished by the presence of biphasic components; there can be morphological and/or immunohistochemical substantiation of epithelial and mesenchymal differentiation. The patients with this variant have been associated with very poor disease-specific and overall survival rates in comparison with the high-grade pure urothelial carcinoma. Being a rare entity, it usually presents at a higher grade and is related to a dismal prognosis in comparison with conventional urothelial carcinoma. Careful examination, early diagnosis, and effective treatment are the most important steps for good survival. Here, we report a 58-year-old male who presented with complaints of hematuria for one and a half months with histopathology showing features of SVUC.

3.
J Oncol ; 2020: 8541415, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-33273920

RESUMO

The aim of the study is to investigate the expression of angiogenesis (VEGF and PDGF), angiogenesis inhibitor markers (angiostatin and endostatin), proliferation (Ki67), and apoptosis markers (p53 and p16) of cervical cancer in Indian population and to correlate them with the clinicopathological profile. It is a descriptive study of consecutive cases of cervical cancer from Saveetha Medical College and Hospital between January 2017 and December 2018. The expression of angiogenesis, angiogenesis inhibitor markers, Ki67, p53, and p16 in 60 cases of cervical sections were detected by the immunohistochemical method and analyzed with clinicopathological data. VEGF expression was positive in 16 cases (26.67%) and negative in 20 cases (33.33%). As of PDGF, 3 cases (3.33%) have shown positivity to PDGF and 33 cases have shown negativity. Angiostatin and endostatin expression was reported to be positive in 10 (16.67%) and 21 (35%) cases, respectively. Most of the cases 57 (95%) have shown both p16 and Ki67 positivity. Although p53 expression was positive in 48 cases (80%), the remaining 12 cases (20%) were p53-negative. The PDGF expression was significantly correlated to the stage of tumors. No statistically significant association was observed between angiogenesis inhibitor markers and clinicopathological parameters. A significant positive correlation was noticed between the Ki67 expression and stage of tumors.

4.
Turk Patoloji Derg ; 34(1): 108-111, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-28272654

RESUMO

Seborrheic keratosis is a benign lesion that is common in the trunk and head and neck regions. It shows a considerable variety of histological appearances leading to different variants. The presence of sebaceous differentiation in seborrheic keratosis is very rare and can histologically mimic benign and malignant tumors with sebaceous differentiation. We present a case of a 65-year-old male presenting with multiple nodules over the right and left sides of neck and the right preauricular region, histopathological examination of which revealed multiple pigmented seborrheic keratoses with sebaceous differentiation. This case is reported for its rare sebaceous differentiation and multiplicity along with the importance of differentiating it from a variety of benign to malignant neoplasms showing sebaceous differentiation.


Assuntos
Ceratose Seborreica/patologia , Idoso , Diferenciação Celular , Humanos , Masculino , Glândulas Sebáceas/patologia
5.
Eur J Neurol ; 24(2): 341-348, 2017 02.
Artigo em Inglês | MEDLINE | ID: mdl-27943468

RESUMO

BACKGROUND AND PURPOSE: Mild cognitive impairment (MCI) is associated with pronounced grey matter atrophy in various brain regions. However, the association between atrophy patterns and progression from no cognitive impairment (NCI) to Parkinson's disease (PD)-MCI is not clearly known. We investigated the pattern and progression of atrophy in subcortical structures and its impact on cognition in patients with mild PD. METHODS: Sixty-five patients with mild PD with baseline and longitudinal clinical and neuropsychological assessments, and structural magnetic resonance imaging scans were studied. Movement Disorder Society Task Force criteria were used to classify patients with PD into PD-NCI (n = 54) and PD-MCI (n = 11). Based on progression over time, those who remained without cognitive impairment were classified as PD-stable (n = 42) and those who converted to MCI over 18 months were classified as PD-converters (n = 12). FreeSurfer was used to measure cortical thickness and subcortical volumes at baseline and follow-up. RESULTS: Parkinson's disease-MCI showed baseline thalamus atrophy and progressive atrophy in the thalamus, caudate, presubiculum, cornu ammonis 1 and 2-3, and significant memory and executive dysfunction compared with PD-NCI. PD-converters had greater accumbens atrophy at baseline and progressive atrophy in the thalamus, caudate and accumbens with dysfunctions in memory and executive domains. CONCLUSIONS: Progression of cognitive impairment in non-demented PD is associated with a specific pattern of subcortical atrophy. Findings from this study will allow future studies to investigate in the role of subcortical structures as a biomarker for PD dementia.


Assuntos
Córtex Cerebral/patologia , Transtornos Cognitivos/patologia , Transtornos Cognitivos/psicologia , Doença de Parkinson/patologia , Doença de Parkinson/psicologia , Idoso , Atrofia , Transtornos Cognitivos/etiologia , Disfunção Cognitiva/etiologia , Disfunção Cognitiva/psicologia , Progressão da Doença , Função Executiva , Feminino , Humanos , Estudos Longitudinais , Imageamento por Ressonância Magnética , Masculino , Memória , Pessoa de Meia-Idade , Testes Neuropsicológicos , Doença de Parkinson/complicações
7.
J Clin Diagn Res ; 9(4): QJ01, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26023608
8.
Eur J Neurol ; 22(1): 150-5, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25142829

RESUMO

BACKGROUND AND PURPOSE: Whilst there is evidence implicating small vessel cerebrovascular disease in the pathogenesis of Alzheimer's disease (AD), its specific contribution to the pathophysiology of AD remains unclear. The burden of small vessel cerebrovascular disease visualized as white matter hyperintensity (WMH) and its association with medial temporal atrophy (MTA) at different stages of AD was studied. METHODS: One hundred and sixty-five cognitively normal (CN) community controls, 103 mild cognitive impairment (MCI) patients, 141 mild AD patients and 68 moderate-severe AD patients were studied. Clinical, cognitive and risk factor data were collected, and WMH and MTA were quantified by trained raters. The Jonckheere-Terpstra test for ordered alternatives was used to study the association between WMH and MTA in different stages of AD. RESULTS: The burden of total WMH increased significantly with increasing severity of AD, even after correcting for confounders. The proportion of CN, MCI, mild AD and moderate-severe AD subjects with severe burden of WMH was 6.7%, 9.7%, 28.4%, and 39.7%, respectively. A strong positive association between WMH severity and MTA was evident amongst MCI (P = 0.011) and mild AD (P = 0.003) subjects, but not in CN (P = 0.953) and moderate-severe AD subjects (P = 0.301). CONCLUSIONS: The burden of WMH increased significantly from the stage of CN to MCI to AD. The association between WMH and MTA was greatest at the stage of MCI and mild AD. This has implications on the strategy to slow the progression of AD, where measures to reduce WMH, including control of vascular risk factors, need to be optimized at the stage of MCI and mild AD.


Assuntos
Doença de Alzheimer/patologia , Doenças de Pequenos Vasos Cerebrais/patologia , Disfunção Cognitiva/patologia , Lobo Temporal/patologia , Substância Branca/patologia , Idoso , Idoso de 80 Anos ou mais , Doença de Alzheimer/epidemiologia , Atrofia/epidemiologia , Atrofia/patologia , Doenças de Pequenos Vasos Cerebrais/epidemiologia , Disfunção Cognitiva/epidemiologia , Comorbidade , Progressão da Doença , Feminino , Humanos , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Índice de Gravidade de Doença , Singapura/epidemiologia
10.
Vascular ; 22(6): 448-9, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24347137

RESUMO

We report a case of hypothenar hammer syndrome. The case presents necessary diagnostic measures and discusses the etiology of this syndrome. Additionally, the case reviews treatments, which culminated in the eventual use of ulnar artery bypass with autogenous basilica vein to treat and resolve the ischemic fingers of the patient.


Assuntos
Dedos/irrigação sanguínea , Dedos/patologia , Doença Arterial Periférica/cirurgia , Doença de Raynaud/etiologia , Úlcera Cutânea/patologia , Idoso , Artérias/cirurgia , Implante de Prótese Vascular , Dilatação Patológica , Gangrena , Humanos , Masculino , Doença Arterial Periférica/complicações , Síndrome , Trombose/complicações , Trombose/cirurgia , Veias/cirurgia , Veias/transplante
12.
Indian J Pathol Microbiol ; 55(4): 521-4, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-23455794

RESUMO

Gliosarcoma is a rare variant of glioblastoma with a biphasic pattern showing glial and mesenchymal differentiation. It is seen in adults during their fifth to sixth decades of life and is extremely rare in children. We report a case of primary gliosarcoma with fibrosarcomatous differentiation in an 11-year-old boy presenting with headache and vomiting. Imaging showed a contrast-enhancing isodense space-occupying lesion with areas of calcification in the right temporoparietal cortex. A total excision was done and, on histopathologic examination, a differential diagnostic consideration of gliosarcoma and teratoma with malignant transformation was made. After immunohistochemical analysis, a final diagnosis of gliosarcoma with fibrosarcomatous differentiation was then made. Primary gliosarcoma is a very rare tumor in children with a poor prognosis.


Assuntos
Neoplasias Encefálicas/diagnóstico , Neoplasias Encefálicas/patologia , Fibrossarcoma/diagnóstico , Fibrossarcoma/patologia , Gliossarcoma/diagnóstico , Gliossarcoma/patologia , Biomarcadores Tumorais/análise , Encéfalo/diagnóstico por imagem , Criança , Histocitoquímica , Humanos , Imuno-Histoquímica , Imageamento por Ressonância Magnética , Masculino , Microscopia , Tomografia Computadorizada por Raios X
14.
Artigo em Inglês | MEDLINE | ID: mdl-21096802

RESUMO

High Frequency Oscillations (HFOs) in the EEG are a promising biomarker of epileptogenic tissue. Given that the visual marking of HFOs is highly time-consuming and subjective, automatic detectors are necessary. In this study, we present a novel automatic detector that detects HFOs by incorporating information of previously detected baselines. The detector was trained on 72 channels and tested on 278, achieving a mean sensitivity of 96.8% with a mean false positive rate of 4.86%. This low rate is reasonable since only visually marked baseline segments were considered as the true negatives. This detector could be useful for the systematic study of HFOs and for their eventual clinical application.


Assuntos
Eletrodos Implantados , Epilepsia/cirurgia , Oscilometria/métodos , Processamento de Sinais Assistido por Computador , Automação , Mapeamento Encefálico/métodos , Desenho de Equipamento , Reações Falso-Positivas , Humanos , Modelos Estatísticos , Curva ROC , Reprodutibilidade dos Testes , Sensibilidade e Especificidade
15.
Ind Psychiatry J ; 19(1): 37-40, 2010 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-21694789

RESUMO

BACKGROUND: Emotional stability remains the central theme in personality studies. The concept of stable emotional behavior at any level is that which reflects the fruits of normal emotional development. The study aims at development of an emotional stability scale. MATERIALS AND METHODS: Based on available literature the components of emotional stability were identified and 250 items were developed, covering each component. Two-stage elimination of items was carried out, i.e. through judges' opinions and item analysis. RESULTS: Fifty items with highest 't' values covering 5 dimensions of emotional stability viz pessimism vs. optimism, anxiety vs. calm, aggression vs. tolerance., dependence vs. autonomy., apathy vs. empathy were retained in the final scale. Reliability as checked by Cronbach's alpha was .81 and by split half method it was .79. Content validity and construct validity were checked. Norms are given in the form of cumulative percentages. CONCLUSION: Based on the psychometric principles a 50 item, self-administered 5 point Lickert type rating scale was developed for measurement of emotional stability.

16.
Curr Pharm Des ; 15(7): 732-41, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19275639

RESUMO

Prodigiosins are a family of bright red colored bacterial pigment and derive their name from the miraculous (prodigious) events associated with their occurrence. They indeed seem to be living upto their name as a host of activities such as anti-microbial, anti-malarial, anti-cancer and immunosuppressive have been associated with them. Out of these, immunosuppressive and anti-cancer activity has received more importance as it has a clinical promise. Prodigiosins, isolated mostly from Gram negative bacteria are characterized by a common pyrryldipyrrylmethene structure with varying side chains. The review discusses the mechanisms involved in the anti-cancer activity of this class of compounds. In vitro, prodigiosins have been shown to primarily target the cancer cells independently of the p53 status while little or no effect has been observed on normal cells. In addition, prodigiosins are effective in cancer cells with multidrug resistance phenotype and defects in the apoptotic pathways. These make prodigiosins attractive candidates for further development. Though the molecular targets of prodigiosins have not been clearly defined, they have been found to target different signaling pathways possibly through induction of DNA double strand breaks and/ or neutralization of pH gradients leading to changes in cell cycle proteins and apoptosis. The review will discuss the recent findings related to the mechanism involved in the anti-cancer activity of this class of molecules.


Assuntos
Antineoplásicos/farmacologia , Prodigiosina/farmacologia , Animais , Antineoplásicos/química , Antineoplásicos/isolamento & purificação , Antineoplásicos/uso terapêutico , Apoptose/efeitos dos fármacos , Ciclo Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Dano ao DNA , Bactérias Gram-Negativas/metabolismo , Humanos , Neoplasias/tratamento farmacológico , Prodigiosina/química , Prodigiosina/isolamento & purificação , Prodigiosina/uso terapêutico , Fatores de Transcrição/metabolismo
17.
Bioorg Med Chem Lett ; 17(6): 1808-11, 2007 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-17197179

RESUMO

The plant Aegle marmelos belongs to the family of Rutaceae. From the leaves of A. marmelos an alkaloidal-amide, Aegeline 2, was isolated and found to have antihyperglycemic activity as evidenced by lowering the blood glucose levels by 12.9% and 16.9% at 5 and 24h, respectively, in sucrose challenged streptozotocin induced diabetic rats (STZ-S) model at the dose of 100mg/kg body weight. Aegeline 2 has also significantly decreased the plasma triglyceride (Tg) levels by 55% (P<0.001), total cholesterol (TC) by 24% (P<0.05), and free fatty acids (FFA) by 24%, accompanied with increase in HDL-C by 28% and HDL-C/TC ratio by 66% in dyslipidemic hamster model at the dose of 50mg/kg body weight. The reasonable mapping of compound 2 to validated pharmacophoric hypothesis and 3D QSAR model with an estimated activity (283nM) suggest that the compound 2 might be a beta(3)-AR agonist.


Assuntos
Aegle/química , Hipoglicemiantes/isolamento & purificação , Hipoglicemiantes/farmacologia , Hipolipemiantes/isolamento & purificação , Hipolipemiantes/farmacologia , Agonistas de Receptores Adrenérgicos beta 3 , Agonistas Adrenérgicos beta/isolamento & purificação , Agonistas Adrenérgicos beta/farmacologia , Animais , Glicemia/metabolismo , Colesterol/sangue , HDL-Colesterol/sangue , Cricetinae , Diabetes Mellitus Experimental/sangue , Diabetes Mellitus Experimental/tratamento farmacológico , Gorduras na Dieta , Ácidos Graxos não Esterificados/sangue , Masculino , Modelos Moleculares , Fosfolipídeos/sangue , Ratos , Ratos Sprague-Dawley , Triglicerídeos/sangue
18.
Toxicon ; 48(8): 1011-7, 2006 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-16982078

RESUMO

Traditionally the potency of ASVS is assayed quantitatively by in-vivo neutralization test for lethality in mice. A sensitive and simple in-vitro agglutination assay for the quantitative determination of Antisnake Venom Serum (ASVS) potency is reported. The method is rapid, cheap, simple, economical and above all does not require the use of experimental animals for potency assay of in process, unpurified and purified sera batches. Among in-vitro procedures, agglutination assay was favored in comparison to flocculation as the later was found to give variable results and also time consuming (high Kf value). Before application, the method was standardized and validated for choice and concentration of particulate material (latex vs. bentonite), temperature and optimum antiserum concentration. It is well known fact that venoms lose toxicity on dilution however this study demonstrated that the bentonite adsorbed venoms of the entire four snake species viz., Cobra, Krait, Russell's viper and Echis are stable even up to 30 days of storage. Among five lots each of unpurified serum, unprocessed plasma and purified sera tested, the results were found comparable with universally accepted in-vivo biological assay. The coefficient of correlation was found to be near 1.0 within 95% fiducial limits of acceptance and also significantly less variation was observed in the mean potency values and standard deviations. For all results p value was observed to be <0.01. Results indicate that in-vitro agglutination assay is suitable and can be used for potency estimation of in process as well as unpurified and purified ASVS batches.


Assuntos
Testes de Aglutinação/métodos , Antivenenos/farmacologia , Venenos de Serpentes/antagonistas & inibidores , Adsorção , Testes de Aglutinação/economia , Antivenenos/química , Bentonita/química , Temperatura
19.
Biochem Biophys Res Commun ; 305(2): 215-22, 2003 May 30.
Artigo em Inglês | MEDLINE | ID: mdl-12745061

RESUMO

Fenofibrate is the ligand for PPARalpha subtype that mediates the action of its agonists' in lipid metabolism. How fibrate exerts hypolipidemic effect? The mechanism is studied in a newly developed high-fat fructose enriched diet induced dyslipidemia-diabetic hamster model. Fenofibrate lowered the basal plasma lipids like TC, TG, PL, FFA, glycerol, VLDL, and LDL, but HDL was increased. The activity of lipoprotein lipase in liver, adipose tissue, and small intestine was upregulated. However, that of triglyceride lipase was downregulated in liver. It has also improved the insulin secretion and plasma glucose lowering, caused by impairment in insulin secretion due to high-fat load. The drug was found effective in reducing body weight and diet due to rise in leptin level. Fenofibrate also enhanced the fecal excretion of total lipids, cholic acid, and deoxycholic acid probably by the activation of 7alpha cholesterol hydroxylase enzyme. Thus, causing broad-spectrum lipid lowering along with inhibition of hepatic lipid biosynthesis and maintaining lipid-glucose homeostasis.


Assuntos
Diabetes Mellitus/tratamento farmacológico , Fenofibrato/farmacologia , Hiperlipidemias/tratamento farmacológico , Hipoglicemiantes/farmacologia , Hipolipemiantes/farmacologia , Animais , Ácidos e Sais Biliares/análise , Glicemia/análise , Cricetinae , Diabetes Mellitus/sangue , Diabetes Mellitus/metabolismo , Gorduras/administração & dosagem , Fezes/química , Fenofibrato/uso terapêutico , Hiperlipidemias/sangue , Hiperlipidemias/metabolismo , Hipoglicemiantes/uso terapêutico , Hipolipemiantes/uso terapêutico , Insulina/sangue , Lipase/metabolismo , Lipídeos/análise , Lipídeos/biossíntese , Lipídeos/sangue , Lipase Lipoproteica/metabolismo , Fígado/metabolismo , Masculino , Mesocricetus , Receptores Citoplasmáticos e Nucleares/agonistas , Distribuição Tecidual , Fatores de Transcrição/agonistas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...